0001209191-19-046968.txt : 20190821 0001209191-19-046968.hdr.sgml : 20190821 20190821160602 ACCESSION NUMBER: 0001209191-19-046968 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190820 FILED AS OF DATE: 20190821 DATE AS OF CHANGE: 20190821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walsh Jeffrey T. CENTRAL INDEX KEY: 0001578251 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 191043179 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-20 0 0001293971 bluebird bio, Inc. BLUE 0001578251 Walsh Jeffrey T. C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Strategy Officer Common Stock 2019-08-20 4 M 0 500 24.47 A 41421 D Common Stock 2019-08-20 4 S 0 500 124.00 D 40921 D Stock Option (right to buy) 24.47 2019-08-20 4 M 0 500 0.00 D 2024-03-03 Common Stock 500 9521 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 16, 2019. This option vested over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter. /s/ Helen Fu, Attorney-in-Fact 2019-08-21